Hocus Locus, a life sciences company based at the University at Albany's East Campus, has received an investment from the Eastern New York Angels, an early-stage seed investment fund.

Hocus Locus developed a protein switching technology that can be used by stem cell researchers.

"Hocus Locus has developed a diagnostic kit that allows researchers to detect the real-time production of specific miRNAs in living cells without destroying them in the process," said Ted Eveleth, the company's chairman. "This represents an important advance for basic biological research."

While the amount of the investment wasn't revealed, ENYA investments range from $50,000 to $250,000.